SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)] [amend]
SEC Accession No. 0001193125-13-337013
Filing Date
2013-08-16
Accepted
2013-08-15 21:56:42
Documents
9
Period of Report
2013-06-30
Filing Date Changed
2013-08-15

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q/A d585805d10qa.htm 10-Q/A 22218
2 EX-31.1 d585805dex311.htm EX-31.1 5770
3 EX-32.1 d585805dex321.htm EX-32.1 3380
  Complete submission text file 0001193125-13-337013.txt   5934073

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT rgls-20130630.xml EX-101.INS 619440
5 XBRL TAXONOMY EXTENSION SCHEMA rgls-20130630.xsd EX-101.SCH 35673
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rgls-20130630_cal.xml EX-101.CAL 47516
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rgls-20130630_def.xml EX-101.DEF 234563
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE rgls-20130630_lab.xml EX-101.LAB 320820
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rgls-20130630_pre.xml EX-101.PRE 270584
Mailing Address 3545 JOHN HOPKINS COURT SUITE 210 SAN DIEGO CA 92121
Business Address 3545 JOHN HOPKINS COURT SUITE 210 SAN DIEGO CA 92121 858-202-6300
Regulus Therapeutics Inc. (Filer) CIK: 0001505512 (see all company filings)

IRS No.: 264738379 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 001-35670 | Film No.: 131043740
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1